Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.
Tolman
Keith G
KG
Division of Gastroenterology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. keith.tolman@hsc.utah.edu
Fonseca
Vivian
V
Dalpiaz
Anthony
A
Tan
Meng H
MH
D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000145:classification* / Q000150:complications / Q000628:therapy; D005234:Fatty Liver / Q000150:complications / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008107:Liver Diseases / Q000145:classification* / Q000150:complications / Q000628:therapy; D008111:Liver Function Tests; D012449:Safety
D001549:Benzamides; D007004:Hypoglycemic Agents; C030516:meglitinide